A phase II study of zandelisib in patients with relapsed or refractory indolent non‐Hodgkin lymphoma: ME‐401‐K02 study

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

British Journal of Haematology

Topics

Physics

Materials Science

Medicine

Internal Medicine

Hematology

Show all topics

DOI

10.1111/bjh.19994

License

CC-BY-NC

Other Formats

PDF